PhorMed is pleased to add three members to its advisory board and is honored to announce Professor Xi Zheng, Professor Renping Zhou, and Sean O’Connell, Ph.D.
These advisory board members have a combined 98 years of experience in oncology, neurology, and hematology, with 190 peer reviewed publications between them. “They are well received and are a great asset to the company. Their extensive knowledge of our technology and close workings with the inventor will help guide the technology to its end goals”, said Mr. Ben Chang, Chairman.
